The number of respondents who announce that their articles contain more than 0.1% of an SVHC is extremely low considering the targeted choice of articles in the present study, while publicly available data indicate that a lot of consumer articles today still contain SVHCs above the threshold of 0.1%.
Large number of included articles in the present study makes the evidence stronger to propose a consistent effect of SLC11A1 polymorphisms in different populations.
There are some haplotypes (or more generally, some haplogroups) that have been reported as contributing to the risk of a disease, as it is the case of several of articles discussed in the present study.
Tables 1 and 2 contain a description of the 26 articles included in the present study as well as the 76 cost estimates contained in these articles, more than one paper contained more than one cost estimate.
The codification of the articles was performed by the authors of the present study, after previously agreeing on the meaning of the different categories in the instrument.
We evaluated the individual error rate by using the set of 14 articles read by the seven authors of the present study.
The objective of this article is to describe the design of the present study and inform others on the possibilities of performing end-of-life care research in end-stage chronic organ failure, especially in COPD, CHF or CRF.
The purpose of this article is to describe the design of the present study and inform others on the possibilities of performing end-of-life care research in advanced chronic kidney disease.
We conclude this article by discussing a number of limitations of the present study.
Upon completion of the present study, an article by Duran et al. was published, showing that metabolism of glutamine, through glutaminase and GLUD, stimulates MTOR signaling by enhancing GTP-loading of RRAG and reduces the steady-state level of autophagosomes within the cell (as predicted in refs. 1, 16, 17).
